Fatemeh Mosaffa

2.3k total citations
86 papers, 1.9k citations indexed

About

Fatemeh Mosaffa is a scholar working on Molecular Biology, Oncology and Plant Science. According to data from OpenAlex, Fatemeh Mosaffa has authored 86 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Molecular Biology, 32 papers in Oncology and 12 papers in Plant Science. Recurrent topics in Fatemeh Mosaffa's work include Drug Transport and Resistance Mechanisms (19 papers), RNA Interference and Gene Delivery (12 papers) and Genomics, phytochemicals, and oxidative stress (9 papers). Fatemeh Mosaffa is often cited by papers focused on Drug Transport and Resistance Mechanisms (19 papers), RNA Interference and Gene Delivery (12 papers) and Genomics, phytochemicals, and oxidative stress (9 papers). Fatemeh Mosaffa collaborates with scholars based in Iran, Canada and Germany. Fatemeh Mosaffa's co-authors include Javad Behravan, Mahmoud Reza Jaafari, Ali Badiee, Gholamreza Karimi, Khalil Abnous, Razieh Ghodsi, Leila Arabi, Mehrdad Iranshahi, Farzin Hadizadeh and Farhad Eisvand and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Fatemeh Mosaffa

85 papers receiving 1.9k citations

Peers

Countries citing papers authored by Fatemeh Mosaffa

Since Specialization

Citations

This map shows the geographic impact of Fatemeh Mosaffa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fatemeh Mosaffa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fatemeh Mosaffa more than expected).

Fields of papers citing papers by Fatemeh Mosaffa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fatemeh Mosaffa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fatemeh Mosaffa. The network helps show where Fatemeh Mosaffa may publish in the future.

Co-authorship network of co-authors of Fatemeh Mosaffa

This figure shows the co-authorship network connecting the top 25 collaborators of Fatemeh Mosaffa. A scholar is included among the top collaborators of Fatemeh Mosaffa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fatemeh Mosaffa. Fatemeh Mosaffa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Targeting the PERK/NRF2 pathway: Enhancing cisplatin efficacy in resistant ovarian cancer cells via MRP1 and ROS modulation 2025 ·Food and Chemical Toxicology ·Seyedeh Sara Ghorbanhosseini, (unknown), Fatemeh Mosaffa, Mahmoud Aghaei	0
2	Foretinib, a c-MET receptor tyrosine kinase inhibitor, tackles multidrug resistance in cancer cells by inhibiting ABCB1 and ABCG2 transporters 2024 ·Toxicology and Applied Pharmacology ·Somayeh Nazari, Fatemeh Mosaffa, Alireza Poustforoosh, Motahareh Mortazavi, Luciano Saso, Omidreza Firuzi, Fatemeh Moosavi	6
3	Some virulence genes are associated with antibiotic susceptibility in Enterobacter cloacae complex 2024 ·BMC Infectious Diseases ·Fatemeh Mosaffa, Fereshteh Saffari, (unknown), (unknown)	2
4	Tamoxifen resistance induction results in the upregulation of ABCG2 expression and mitoxantrone resistance in MCF-7 breast cancer cells 2023 ·Naunyn-Schmiedeberg s Archives of Pharmacology ·(unknown), (unknown), (unknown), Khadijeh Jamialahmadi, Fatemeh Mosaffa	3
5	Glucosamine attenuates drug resistance in Mitoxantrone-resistance breast cancer cells 2021 ·Journal of Pharmacy and Pharmacology ·(unknown), (unknown), Fatemeh Mosaffa, Khadijeh Jamialahmadi	9
6	Increased Expression of DNA Methyltransferase 1 and 3B Correlates with Tumor Grade in Laryngeal Squamous Cell Carcinoma 2020 ·Pharmaceutical Sciences ·(unknown), Fatemeh Mosaffa, (unknown), (unknown), Khadijeh Jamialahmadi	1
7	Increased Expression of Gankyrin and Stemness Factor Oct-4 are Associated with Unfavorable Clinical Outcomes and Poor Benefit of Tamoxifen in Breast Carcinoma Patients 2019 ·Pathology & Oncology Research ·(unknown), Fatemeh Mosaffa, (unknown), Masoumeh Gharib, Khadijeh Jamialahmadi	12
8	Glucosamine reverses drug resistance in MRP2 overexpressing ovarian cancer cells 2019 ·European Journal of Pharmacology ·(unknown), (unknown), Fatemeh Mosaffa, Khadijeh Jamialahmadi	10
9	Immunogenicity and antitumor activity of the superlytic λF7 phage nanoparticles displaying a HER2/neu-derived peptide AE37 in a tumor model of BALB/c mice 2018 ·Cancer Letters ·Nastaran Barati, Atefeh Razazan, (unknown), Roderick Slavcev, Atefeh Arab, Fatemeh Mosaffa, Amin Reza Nikpoor, Ali Badiee, Mahmoud Reza Jaafari, Javad Behravan	26
10	Altered DNA methyltransferases promoter methylation and mRNA expression are associated with tamoxifen response in breast tumors 2018 ·Journal of Cellular Physiology ·(unknown), Fatemeh Mosaffa, Àmirnader Emami Razavi, Ladan Teimoori‐Toolabi, Khadijeh Jamialahmadi	32
11	The effect of mesoporous silica nanoparticles loaded with epirubicin on drug-resistant cancer cells 2017 ·SHILAP Revista de lepidopterología ·Mohammad Yahya Hanafi‐Bojd, Legha Ansari, Fatemeh Mosaffa, Bizhan Malaekeh‐Nikouei	10
12	A nano-liposome vaccine carrying E75, a HER-2/neu-derived peptide, exhibits significant antitumour activity in mice 2017 ·Journal of drug targeting ·Atefeh Arab, Javad Behravan, Atefeh Razazan, Zahra Gholizadeh, Amin Reza Nikpoor, Nastaran Barati, Fatemeh Mosaffa, Ali Badiee, Mahmoud Reza Jaafari	38
13	Nanolipoparticles-mediated MDR1 siRNA delivery: preparation, characterization and cellular uptake 2015 ·SHILAP Revista de lepidopterología ·(unknown), Javad Behravan, Hermann Lage, Khalil Abnous, Fatemeh Mosaffa, Ali Badiee, Mahmoud Reza Jaafari	7
14	Preparation and evaluation of polyethylenimine-functionalized carbon nanotubes tagged with 5TR1 aptamer for targeted delivery of Bcl-xL shRNA into breast cancer cells 2015 ·Colloids and Surfaces B Biointerfaces ·Sahar Taghavi, (unknown), Fatemeh Mosaffa, Saeedeh Askarian, Khalil Abnous, Mohammad Ramezani	66
15	Protective effects of aqueous and ethanol extracts of rosemary on H ₂ O ₂ -induced oxidative DNA damage in human lymphocytes by comet assay 2014 ·Journal of Complementary and Integrative Medicine ·Kamal Razavi-Azarkhiavi, Javad Behravan, Fatemeh Mosaffa, (unknown), Kobra Shirani, Gholamreza Karimi	26
16	In vitro protective effects of Scutellaria litwinowii root extract against H ₂ O ₂ -induced DNA damage and cytotoxicity 2014 ·Journal of Complementary and Integrative Medicine ·(unknown), Hamideh Parhiz, (unknown), Seyed Ahmad Emami, Javad Asili, Javad Behravan, Fatemeh Mosaffa	5
17	Effect of Curcumin on Doxorubicin-induced Cytotoxicity in H9c2 Cardiomyoblast Cells 2011 ·(unknown), Javad Behravan, Fatemeh Mosaffa, Gholamreza Bahrami, Ahmad Reza Bahrami, Gholamreza Karimi	19
18	Evaluation of antigenotoxicity effects of umbelliprenin on human peripheral lymphocytes exposed to oxidative stress 2008 ·Cell Biology and Toxicology ·Fatemeh Soltani, Fatemeh Mosaffa, Mehrdad Iranshahi, Gholamreza Karimi, (unknown), Fatemeh Haghighi, Javad Behravan	41
19	In vitro Protective Effects of Satureja hortensis L. Essential Oil and Ethanolic Extract on Lymphocytes DNA 2007 ·SHILAP Revista de lepidopterología ·Javad Behravan, Fatemeh Mosaffa, Gholamreza Karimi, Mehrdad Iranshahi	2
20	Effect of Particle Size, Compaction Force and Presence of Aerosil 200 on the Properties of Matrices Prepared from Physical Mixture of Propranolol Hydrochloride and Eudragit RS or RL 2007 ·Fatemeh Sadeghi, Fatemeh Mosaffa, Hadi Afrasiabi Garekani	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact